The deubiquitinase OTUB1 inhibits gluconeogenesis by stabilizing YWHAB
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Qingwen Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People…. Hauptthemen laut MEDLINE: Gluconeogenesis, Diabetes Mellitus, Type 2. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Hepatic gluconeogenesis plays a crucial role in maintaining glucose homeostasis and serves as a potential therapeutic target for type 2 diabetes, while its underlying mechanisms are not fully understood. This study elucidates the role of the deubiquitinase OTU domain-containing ubiquitin aldehyde binding protein 1 (OTUB1) in gluconeogenesis. We found that hepatic OTUB1 expression is reduced in both db/db mice and patients with type 2 diabetes. Deletion of hepatic OTUB1 significantly elevates fasting blood glucose levels and increases the expression of key gluconeogenic genes. Conversely, overexpression of OTUB1 in hepatocytes mitigates diabetic hyperglycemia and enhances insulin sensitivity. It is known that the tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein β (YWHAB) functions as an inhibitor of hepatic gluconeogenesis by interacting with forkhead box protein O (FOXO1) and glucagon receptor (GPCR), but its own modification mechanism remains unclear. Our findings indicate that OTUB1 interacts with YWHAB and deubiquitinates it through a catalytic process, which in turn suppresses gluconeogenesis. Therefore, OTUB1 plays a pivotal role in inhibiting hepatic gluconeogenesis, highlighting its potential as a therapeutic target for type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Senile Chronic Diseases, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Zhejiang 310006,…
- Department of General Practice, The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, China.
- College of Mechanical Engineering, Zhejiang University of Technology, Hangzhou 310023, China.
- Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
- Department of Biomedical Engineering, Research Center for Nano-Biomaterials & Regenerative Medicine, College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.
Zitieren
APA
Zhao, Q., Wang, Q., Li, B., Han, S., Zhang, Y., Wang, Y., Lu, R., Chen, Q., Sun, Z., Ding, M., Liang, Z., & Gao, Y. (2024). The deubiquitinase OTUB1 inhibits gluconeogenesis by stabilizing YWHAB. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111408
Vancouver
Zhao Q, Wang Q, Li B, Han S, Zhang Y, Wang Y, et al. The deubiquitinase OTUB1 inhibits gluconeogenesis by stabilizing YWHAB. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111408
BibTeX
@article{Zhao2024,
author = {Zhao, Qingwen and Wang, Qianzhuo and Li, Bei and Han, Shuang and Zhang, Yingjuan and Wang, Yule and Lu, Ruiling and Chen, Qingyan and Sun, Zhe and Ding, Meng and Liang, Ziwei and Gao, Yue},
title = {The deubiquitinase OTUB1 inhibits gluconeogenesis by stabilizing YWHAB},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111408}
}
EUVIMED